Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,058 | 107,511 | 78,420 | 142,157 | 209,324 |
| Marketable Securities | 202,113 | 196,421 | 176,829 | 147,843 | 112,560 |
| TOTAL | $291,391 | $312,619 | $261,792 | $296,826 | $330,297 |
| Non-Current Assets | |||||
| PPE Net | 26,824 | 26,328 | 25,045 | 23,265 | 21,021 |
| Investments And Advances | 13,177 | 0 | 0 | 5,901 | 9,863 |
| Other Non-Current Assets | 12,761 | 608 | 626 | 664 | 664 |
| TOTAL | $52,762 | $26,936 | $25,671 | $29,830 | $31,548 |
| Total Assets | $344,153 | $339,555 | $287,463 | $326,656 | $361,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,517 | 8,833 | 13,890 | 8,211 | 6,252 |
| Accrued Expenses | 25,588 | 29,144 | 23,545 | 27,844 | 24,127 |
| Other current liabilities | 19 | 35 | 16 | 39 | 33 |
| TOTAL | $38,091 | $38,012 | $37,451 | $36,094 | $30,412 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,268 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 12,493 | 2,596 | 2,848 | 2,724 | 2,341 |
| TOTAL | $49,761 | $2,596 | $2,848 | $2,724 | $2,341 |
| Total Liabilities | $87,852 | $40,608 | $40,299 | $38,818 | $32,753 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,492 | 62,186 | 58,731 | 58,477 | 58,095 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -530,449 | -476,234 | -419,236 | -367,535 | -314,982 |
| Other shareholders' equity | 63 | -108 | -138 | -123 | -125 |
| TOTAL | $256,301 | $298,947 | $247,164 | $287,838 | $329,092 |
| Total Liabilities And Equity | $344,153 | $339,555 | $287,463 | $326,656 | $361,845 |